Nirmal Bang's top stock picks in the pharma sector include Ajanta Pharma, Dr. Reddy's, JB Chemicals, Eris, Sun Pharma, and Lupin, expected to outperform the IPM.
Pharma companies are anticipated to witness improved margins YoY due to a better product mix, price hike benefits, and normalized cost inflation.
Large caps such as Dr. Reddy's, Sun Pharma, Mankind Pharma, and Ajanta Pharma are expected to show >10% YoY revenue growth, with other companies likely reporting double-digit revenue as well.